Enzyme Immunoassay Market Size Worth USD 25.26 Billion by 2034 | CAGR: 3.64%

The enzyme immunoassay market size is expected to reach USD 25.26 Billion by 2034, according to a new study by Polaris Market Research. The report “Enzyme Immunoassay Market Share, Size, Trends, Industry Analysis Report: By Product (Reagents & Kits, Analyzers/Instruments, Software & Services), By Technology, By Specimen, By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Enzyme immunoassay is a lab method used to identify and measure proteins, hormones, or antibodies with high precision. It is widely used in diagnostics, drug testing, and disease monitoring. Advancements in automation and sensitivity are improving testing speed and accuracy.

Request a free sample copy or read the full market insights: enzyme immunoassay market report

The market growth is driven by rising demand for accurate diagnostic tools, expanding R&D spending, increasing applications in pharmaceutical research, and growing adoption of automated immunoassay systems.

Top of FormEnzyme Immunoassay Market Report Highlights

• Based on product, the reagents & kits segment held the largest share due to its frequent use in routine diagnostic testing.
• Based on technology, the enzyme-linked immunosorbent assay (ELISA) segment accounted for the largest market share in 2024 due to its high accuracy and ease of use.
• Based on specimen, saliva segment witnessed steady growth due to its non-invasive sample collection method.
• Based on application, infectious disease testing segment held the largest share due to rising screening needs across healthcare centers.
• Based on end user, hospitals segment accounted for the largest market share in 2024 driven by increasing patient testing volumes.
• North America hold the largest share of the global enzyme immunoassay market in 2024, fueled by strong healthcare infrastructure and advanced lab facilities.
• Asia Pacific witnessed steady growth due to expanding diagnostic networks and rising disease awareness.
• A few global key market players include Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Becton, Dickinson and Company, Fujirebio Inc., and Revvity Inc.

Polaris Market Research has segmented the market report on the basis of product, technology, specimen, application, end user, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Reagents & Kits
• Analyzers/Instruments
• Software & Services

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Enzyme-Linked Immunospot (ELISPOT) Assay
• Chemiluminescent Enzyme Immunoassay (CLEIA)
• Fluoroenzyme Immunoassay (FEIA)
• Others

By Specimen Outlook (Revenue, USD Billion, 2020–2034)

• Blood
• Saliva
• Urine
• Other Specimens

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Others

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals
• Clinical Laboratories
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America